We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$104M
Cap. Flow %
2.08%
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7 years
Top 10 Avg Time Held Equity + Options
2.9 years
Top 20 Avg Time Held Equity + Options
3.8 years
Avg Time Held Equity only
4.7 years
Top 10 Avg Time Held Equity only
2.9 years
Top 20 Avg Time Held Equity only
3.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.71%
2 Technology 17.21%
3 Healthcare 9.68%
4 Financials 7.2%
5 Communication Services 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DBEF icon
3126
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.26B
$1.23K ﹤0.01%
+28
New +$1.22K
2025 Q2
0 quarters
CABO icon
3127
Cable One
CABO
$48.1M
$1.22K ﹤0.01%
9
-4
-31% -$751
2016 Q4
34 quarters
HROW icon
3128
Harrow
HROW
$1.08B
$1.22K ﹤0.01%
+40
New +$1.07K
2025 Q2
0 quarters
ANAB icon
3129
AnaptysBio
ANAB
$1.46B
$1.22K ﹤0.01%
55
– –
2019 Q4
22 quarters
CBL icon
3130
CBL Properties
CBL
$1.51B
$1.22K ﹤0.01%
48
-80
-63% -$1.97K
2022 Q3
11 quarters
INRO icon
3131
BlackRock US Industry Rotation ETF
INRO
$488M
$1.22K ﹤0.01%
42
– –
2025 Q1
1 quarter
TPC icon
3132
Tutor Perini Cor
TPC
$4.13B
$1.22K ﹤0.01%
26
– –
2024 Q3
3 quarters
CPRX icon
3133
DELISTED
Catalyst Pharmaceutical
CPRX
$1.22K ﹤0.01%
56
+29
+107% +$685
2022 Q3
11 quarters
MWA icon
3134
Mueller Water Products
MWA
$3.38B
$1.2K ﹤0.01%
50
-42
-46% -$1.04K
2024 Q4
2 quarters
RYTM icon
3135
Rhythm Pharmaceuticals
RYTM
$6.06B
$1.2K ﹤0.01%
19
– –
2023 Q4
6 quarters
FBNC icon
3136
First Bancorp
FBNC
$2.5B
$1.2K ﹤0.01%
27
– –
2020 Q2
20 quarters
CEROW icon
3137
DELISTED
CERo Therapeutics Warrants
CEROW
$1.19K ﹤0.01%
50,000
– –
2025 Q1
1 quarter
TRC icon
3138
Tejon Ranch
TRC
$447M
$1.17K ﹤0.01%
69
-15
-18% -$247
2024 Q1
5 quarters
CECO icon
3139
Ceco Environmental
CECO
$3.55B
$1.16K ﹤0.01%
41
– –
2022 Q3
11 quarters
ARVN icon
3140
Arvinas
ARVN
$468M
$1.16K ﹤0.01%
157
+13
+9% +$96
2023 Q3
7 quarters
NBB icon
3141
Nuveen Taxable Municipal Income Fund
NBB
$414M
$1.16K ﹤0.01%
+73
New +$1.13K
2025 Q2
0 quarters
LAR icon
3142
Lithium Argentina AG
LAR
$783M
$1.14K ﹤0.01%
550
-2,880
-84% -$5.74K
2025 Q1
1 quarter
CARS icon
3143
Cars.com
CARS
$548M
$1.14K ﹤0.01%
96
-71
-43% -$782
2022 Q2
12 quarters
CVLG icon
3144
Covenant Logistics
CVLG
$782M
$1.13K ﹤0.01%
47
+2
+4% +$43
2022 Q3
11 quarters
LOB icon
3145
Live Oak Bancshares
LOB
$1.63B
$1.13K ﹤0.01%
38
-71
-65% -$1.92K
2022 Q3
11 quarters
RAMP icon
3146
LiveRamp
RAMP
$2.28B
$1.12K ﹤0.01%
34
– –
2024 Q3
3 quarters
TASK icon
3147
TaskUs
TASK
$781M
$1.12K ﹤0.01%
67
– –
2022 Q4
10 quarters
MCB icon
3148
Metropolitan Bank Holding Corp
MCB
$1.08B
$1.12K ﹤0.01%
16
– –
2024 Q3
3 quarters
OSW icon
3149
OneSpaWorld
OSW
$2.43B
$1.1K ﹤0.01%
54
-65
-55% -$1.19K
2024 Q4
2 quarters
KLC icon
3150
KinderCare Learning Companies
KLC
$217M
$1.1K ﹤0.01%
+109
New +$1.26K
2025 Q2
0 quarters

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.